Michael Lauseker

15PUBLICATIONS
37CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursMedical mycologyMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Feb 19, 2026
Development of a prognostic scoring system for chronic myeloid leukemia in blast phase.

Michael Lauseker, Tomasz Sacha, Hana Klamova

|Dec 19, 2025
Treatment expectations and goals among patients with chronic myeloid leukemia in Germany: a patient-centered perspective.

Philipp Ernst, Cera Lohse, Michael Lauseker

|Apr 15, 2025
Prognostic scoring systems in chronic myeloid leukaemia.

Michael Lauseker, Verena S Hoffmann, Markus Pfirrmann

|Mar 29, 2024
Management and outcome of patients with chronic myeloid leukemia in blast phase in the tyrosine kinase inhibitor era - analysis of the European LeukemiaNet Blast Phase Registry.

Annamaria Brioli, Elza Lomaia, Christian Fabisch

|Sep 19, 2023
Survival with chronic myeloid leukaemia after failing milestones.

Michael Lauseker, Rüdiger Hehlmann, Andreas Hochhaus

|Jul 29, 2023
The Absolute Monocyte Count at Diagnosis Affects Prognosis in Myelodysplastic Syndromes Independently of the IPSS-R Risk Score.

Tobias Silzle, Sabine Blum, Annika Kasprzak

Pageof 3

Frequent Collaborators

5 joint publications

Susanne Saußele

4 joint publications

Andreas Hochhaus

3 joint publications

Tomasz Sacha

3 joint publications

Georg-Nikolaus Franke